Anti-PD1(RetifanlimAb biosimilar) monoclonal Antibody
Produktgrößen
100 µg
£595,00
12-9610-100UG
Über dieses Produkt
- SKU:
- 12-9610
- Zusätzliche Namen:
- Zynyz
- Weitere Details:
- Retifanlimab (Zynyz); is an anti-cancer drug used for the treatment of Mercel cell Carcinoma. Retifanlimab is a Programmed death Receptor 1 (PD-1) blocking Monoclonal antobody. Retifanlimab blocks the interaction between PD-1 and its ligands PD-L1/2; and it acts as an immune checkpoint modulator.
- Isotyp:
- IgG4(P108S)
- Reaktivitäten:
- Human
- Versandbedingungen:
- Blue Ice
- Lagerbedingungen:
- Store at -20[o]C to -80[o]C for 12 months in lyophilized form. After reconstitution; if not intended for use within a month; aliquot and store at -80[o]C (Avoid repeated freezing and thawing). Lyophilized antibodies are shipped at ambient temperature.
- Hersteller:
- Abeomics
- Typ:
- Antibodies:Monoclonal Antibody
- Datenblatt des Herstellers:download_pdf.php